Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Detection of Gross Error: The Q Test01:00

Detection of Gross Error: The Q Test

When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Engraftment of Aligned Cardiac Patches Loaded with hiPSC-CMs in a Large Animal Model of Myocardial Infarction.

Theranostics·2026
Same author

Pilot study on the effects of dapagliflozin on echocardiographic parameters in dogs with symptomatic myxomatous mitral valve disease.

Veterinary and animal science·2025
Same author

Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs.

BMC veterinary research·2023
Same author

Dynamic detection and reversal of myocardial ischemia using an artificially intelligent bioelectronic medicine.

Science advances·2022
Same author

Letter to the editor regarding "Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial".

Journal of veterinary internal medicine·2021
Same author

Myocardial Contractility: Historical and Contemporary Considerations.

Frontiers in physiology·2020

Related Experiment Video

Updated: Jul 16, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

Different species require different correction factors for the QT interval.

Maxim V Soloviev1, Robert L Hamlin, Randy M Barrett

  • 1WIL Research Laboratories, LLC, Ashland, OH 44805, USA. m-soloviev@usa.net

Cardiovascular Toxicology
|February 17, 2007
PubMed
Summary

Different species require distinct QT interval correction formulas for accurate safety pharmacology studies. Cynomolgus monkeys and Beagle dogs show species-specific cardiac repolarization, necessitating tailored approaches for reliable risk assessment.

More Related Videos

In Vivo Surface Electrocardiography for Adult Zebrafish
09:13

In Vivo Surface Electrocardiography for Adult Zebrafish

Published on: August 1, 2019

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

Related Experiment Videos

Last Updated: Jul 16, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

In Vivo Surface Electrocardiography for Adult Zebrafish
09:13

In Vivo Surface Electrocardiography for Adult Zebrafish

Published on: August 1, 2019

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

Area of Science:

  • Pharmacology
  • Cardiology
  • Veterinary Medicine

Background:

  • The International Council for Harmonisation (ICH) S7B guideline mandates QT interval evaluation in vivo to assess fatal tachyarrhythmia risk.
  • While heart rate (HR) correction is recommended, the guideline acknowledges potential inaccuracies in QT interval corrections.
  • Species-specific differences in cardiac repolarization mechanisms can impact the reliability of standard QT correction methods.

Purpose of the Study:

  • To investigate species-specific QT interval variations and evaluate the effectiveness of different correction formulas in cynomolgus monkeys (CM) and Beagle dogs (BD).
  • To determine optimal QT correction methods for each species to ensure accurate safety pharmacology assessments.
  • To highlight the need for individualized approaches in interpreting safety pharmacology data based on species behavior and physiology.

Main Methods:

  • Analysis of 25-hour electrocardiogram (ECG) data from 40 CM and 66 BD healthy control animals.
  • Evaluation of 10,761 ECGs from CM and 24,882 ECGs from BD.
  • Comparison of QT interval variations and assessment of different HR correction formulas (e.g., Bazett's, Van de Water's).

Main Results:

  • Cynomolgus monkeys exhibit significant diurnal QT interval fluctuations (up to 12.7%) due to autonomic nervous tone variations, unlike Beagle dogs.
  • Bazett's correction formula was found to be optimal for CM, while Van de Water's correction performed best for BD.
  • Species-specific differences in cardiac repolarization and diurnal variations necessitate distinct QT correction strategies.

Conclusions:

  • Standardized QT interval correction formulas may not be universally applicable across different species.
  • Optimal QT correction methods vary between cynomolgus monkeys and Beagle dogs, requiring species-specific formula selection.
  • Behavioral and physiological differences between species underscore the importance of tailored interpretations in safety pharmacology studies.